CDP0857 treatment significantly reduced the tumor size and volume of D-K-Ras MT cells harboring these mutations, and tumors excised from xenograft mice showed a significantly reduced expression of CD44, CD133 and EpCAM and of active forms of factors in the Wnt/β-catenin and Ras/ERK pathways. This evidence concerns the gene EPCAM and neoplasm.